His brain is on FIRES.

This article discusses a case of a 13-year-old boy who developed Febrile Infection-Related Epilepsy Syndrome (FIRES) after contracting COVID-19. FIRES is a subtype of New-Onset Refractory Status Epilepticus (NORSE) characterized by new-onset status epilepticus without a clear cause. The boy was treated with Anakinra, a medication used for rheumatologic conditions, and showed a rapid response with seizure control. The article highlights the potential use of Anakinra in COVID-19-associated FIRES and the importance of early treatment. It also mentions the presence of the "claustrum sign" on imaging, which is a biomarker for FIRES. [Extracted from the article]